Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in inventions in biomaterials
4.1.2 Rise in ageing population
4.1.3 High per capita income
4.2 Restraints
4.2.1 Compatibility issues
4.2.2 Safety regulations
4.3 Opportunities
4.3.1 Growing Healthcare industry
4.3.2 Increase in free-trades
4.4 Challenges
4.4.1. Limitations of biomaterial products
Chapter 5 Europe Biomaterials Market - By Specialty
5.1 Cardiology
5.2 Neurology
5.3 Orthopaedics
5.4 Dental
5.5 Gynaecology
5.6 Others
Chapter 6 Europe Biomaterials Market - By Type of Material
6.1 Bioactive material
6.2 Bioinert material
6.3 Bioresorbable material
Chapter 7 Europe Biomaterials Market - By Geography
7.1 Introduction
7.2 Europe
7.2.1. U.K.
7.2.2. Germany
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
Chapter 8 Europe Biomaterials Market - Company Profiles
8.1. BASF SE
8.2. Midatech
8.3. Corbion N.V.
8.4. Berkeley Advanced Biomaterials, Inc.
8.5. Oasmia
8.6. Invibio Ltd.
8.7. Celsense Corporation
8.8. AdvanSource Biomaterials Corp
8.9. Bayer AG
8.10. Wright Medical Group, Inc.
8.11. Dentsply
8.12. DuPont
8.13. Biomet, Inc.
8.14. Zimmer Biomet Holdings, Inc.
8.15. Royal DSM
Chapter 9 Europe Biomaterials Market - Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 10 Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
